BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.21B
1-Year Return
17.73%
This Quarter Return
-7.16%
1 Year Return
+17.73%
3 Year Return
+87.27%
5 Year Return
+258.36%
10 Year Return
+515.25%
AUM
$3.97B
AUM Growth
-$499M
(-11%)
Cap. Flow
-$103M
Cap. Flow
% of AUM
-2.6%
Top 10 Holdings %
Top 10 Hldgs %
7.73%
Holding
1,278
New
86
Increased
451
Reduced
486
Closed
106
Top Buys
| 1 |
Kennametal
KMT
|
+$11.8M |
| 2 |
V2X
VVX
|
+$11M |
| 3 |
Seadrill
SDRL
|
+$10.4M |
| 4 |
Hamilton Insurance Group
HG
|
+$9.64M |
| 5 |
Werner Enterprises
WERN
|
+$9.1M |
Top Sells
| 1 |
Patrick Industries
PATK
|
+$19.9M |
| 2 |
EchoStar
SATS
|
+$13.1M |
| 3 |
HTLF
Heartland Financial USA, Inc.
HTLF
|
+$12.4M |
| 4 |
FB Financial Corp
FBK
|
+$11.1M |
| 5 |
Telephone and Data Systems
TDS
|
+$8.57M |
Sector Composition
| 1 | Financials | 29.13% |
| 2 | Industrials | 11.82% |
| 3 | Consumer Discretionary | 11.45% |
| 4 | Technology | 10.18% |
| 5 | Energy | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Immunic
IMUX
$86M
| $125K | ﹤0.01% |
115,000
-100,000
| -47% | -$109K |
|
1002
RAPT Therapeutics
RAPT
$234M
| $122K | ﹤0.01% |
12,500
-3,125
| -20% | -$30.5K |
|
1003
United-Guardian
UG
$38.9M
| $121K | ﹤0.01% |
13,466
| – | – |
|
1004
SmartRent
SMRT
$269M
| $121K | ﹤0.01% |
+100,000
| New | +$121K |
|
1005
Actinium Pharmaceuticals
ATNM
$50.2M
| $121K | ﹤0.01% |
75,000
-700
| -0.9% | -$1.13K |
|
1006
NetSol Technologies
NTWK
$49.4M
| $118K | ﹤0.01% |
48,892
+2,152
| +5% | +$5.21K |
|
|
FLNT
1007
Fluent
FLNT
$48.1M
| $117K | ﹤0.01% |
53,868
+101
| +0.2% | +$220 |
|
1008
Pioneer Power Solutions
PPSI
$46.6M
| $117K | ﹤0.01% |
39,200
| – | – |
|
|
ACCS
1009
ACCESS Newswire Inc.
ACCS
$42.1M
| $117K | ﹤0.01% |
13,268
-4,000
| -23% | -$35.3K |
|
1010
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $115K | ﹤0.01% |
143,000
-60,000
| -30% | -$48.4K |
|
1011
KORU Medical Systems
KRMD
$187M
| $115K | ﹤0.01% |
+45,305
| New | +$115K |
|
|
IRD
1012
Opus Genetics, Inc. Common Stock
IRD
$79.7M
| $114K | ﹤0.01% |
116,501
| – | – |
|
|
QVCGA
1013
QVC Group, Inc. Series A Common Stock
QVCGA
$83.7M
| $114K | ﹤0.01% |
11,346
+697
| +7% | +$7.01K |
|
1014
Ventyx Biosciences
VTYX
$169M
| $113K | ﹤0.01% |
98,600
-106,900
| -52% | -$123K |
|
1015
Black Diamond Therapeutics
BDTX
$183M
| $113K | ﹤0.01% |
73,100
-71,500
| -49% | -$111K |
|
1016
NeoVolta
NEOV
$154M
| $113K | ﹤0.01% |
+52,200
| New | +$113K |
|
1017
Eledon Pharmaceuticals
ELDN
$155M
| $113K | ﹤0.01% |
33,400
| – | – |
|
1018
Red Robin
RRGB
$111M
| $113K | ﹤0.01% |
31,700
-33,800
| -52% | -$120K |
|
1019
Spero Therapeutics
SPRO
$109M
| $111K | ﹤0.01% |
154,800
-30,000
| -16% | -$21.6K |
|
1020
Urban One Class D
UONEK
$37.7M
| $111K | ﹤0.01% |
154,253
+168
| +0.1% | +$121 |
|
1021
KORE Group Holdings
KORE
$37.6M
| $111K | ﹤0.01% |
44,740
| – | – |
|
1022
Y-mAbs Therapeutics
YMAB
$390M
| $110K | ﹤0.01% |
24,900
-25,000
| -50% | -$111K |
|
1023
Retractable Technologies
RVP
$24.5M
| $109K | ﹤0.01% |
155,630
+10,800
| +7% | +$7.6K |
|
1024
Enanta Pharmaceuticals
ENTA
$178M
| $109K | ﹤0.01% |
19,700
-26,500
| -57% | -$146K |
|
1025
Intellicheck
IDN
$108M
| $109K | ﹤0.01% |
35,847
-25,453
| -42% | -$77.1K |
|